Prostate-specific membrane antigen (PSMA) first discovered in prostate cancer cells is an important target for diagnosis and treatment of prostate cancer.
68
Ga/
18
F-PSMA positron emission tomography (PET)/computed tomography (CT) or PET/magnetic resonance imaging (MRI) plays an important role in prostate cancer. With the rapid development of research and application
liver cancer
lung cancer
kidney cancer and other solid tumors can also accumulate
68
Ga/
18
F-PSMA reflecting theimporta
nt applications of
68
Ga/
18
F-PSMA PET/CT in these tumors. This paper reviewed the application of
68
Ga/
18
F-PSMA PET/CT in the diagnosis and treatment of non-prostate cancer tumors.